Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer

BACKGROUND: Prostate cancer (PCa), the second most common cancer affecting men worldwide, shows a broad spectrum of biological and clinical behaviour representing the epiphenomenon of an extreme heterogeneity. Androgen deprivation therapy is the mainstay of treatment for advanced forms but after few...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cell Commun Signal
Autori principali: Ferrari, Nicoletta, Granata, Ilaria, Capaia, Matteo, Piccirillo, Marina, Guarracino, Mario Rosario, Venè, Roberta, Brizzolara, Antonella, Petretto, Andrea, Inglese, Elvira, Morini, Martina, Astigiano, Simonetta, Amaro, Adriana Agnese, Boccardo, Francesco, Balbi, Cecilia, Barboro, Paola
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2017
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5721601/
https://ncbi.nlm.nih.gov/pubmed/29216878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12964-017-0206-x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi